Lifecore Biomedical, Inc. Insider Trading

LFCR

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jan 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Jan 2025

Jan 8, 2025

Get an email when LFCR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 23, 2025 – May 28, 2025	Aron R. English Large holder	SoldNo plan 3 parts	1,386,060	$6.58 average	$9.13M	84%	Form 4
May 13, 2025	22nw Fund GP, LLC Large holder	SoldNo plan	12,334	$7.00	86K	0.7%	Form 4
May 8, 2025 – May 12, 2025	22nw Fund GP, LLC Large holder	SoldNo plan 3 parts	51,496	$7.03 average	362K	3.0%	Form 4
May 5, 2025 – May 7, 2025	22nw GP, Inc. Large holder	SoldNo plan 3 parts	41,091	$7.05 average	290K	2.3%	Form 4
Jan 8, 2025	Paul Josephs Chief Executive Officer	Bought	17,000	$5.74	98K	3.1%	Form 4

May 23, 2025 – May 28, 2025No plan
Aron R. English
Large holder · sold 1,386,060 at avg $6.58
$9.13M
84% of stake
May 13, 2025No plan
22nw Fund GP, LLC
Large holder · sold 12,334 at $7.00
86K
0.7% of stake
May 8, 2025 – May 12, 2025No plan
22nw Fund GP, LLC
Large holder · sold 51,496 at avg $7.03
362K
3.0% of stake
May 5, 2025 – May 7, 2025No plan
22nw GP, Inc.
Large holder · sold 41,091 at avg $7.05
290K
2.3% of stake
Jan 8, 2025
Paul Josephs
Chief Executive Officer · bought 17,000 at $5.74
98K
3.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LFCR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LFCR

CompareIntrinsic value

ASRTAssertio Holdings Inc.

$9.09+0.28%10

TBPHTheravance Biopharma Inc.

No recent price82

XNCRXencor Inc.

$35.01+14.28%0

ETONEton Pharmaceuticals Inc.

$50.72-0.45%75

SEPNSepterna, Inc.

$47.88+9.57%46

AGIOAgios Pharmaceuticals Inc.

$31.38+0.58%40

GYREGyre Therapeutics Inc.

$4.44+0.00%18

SPRYArs Pharmaceuticals Inc

$3.05+0.00%40

Held by ETFs

LFCR is in 5 US ETFs. The largest of them, with LFCR's weight in each:

Spot a number that looks wrong? Check it in LFCR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LFCR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.